Patent ID: 9067891
Filing Date: 2015-06-30
Classification: A61K,A61P,C07D

Abstract:
1. A method for treating a central nervous system disorder in a human, wherein the central nervous system disorder is an anxiety disorder selected from the group consisting of agoraphobia, generalized anxiety disorder (GAD), obsessive-compulsive disorder (OCD), panic disorder, posttraumatic stress disorder (PTSD), social phobia and other phobias, or a psychotic disorder selected from the group consisting of schizophrenia, schizoaffective disorder and schizophreniform disorder, the method comprising administering to the human an effective amount of a compound of formula including any stereochemically isomeric form thereof, wherein R R A is pyridinyl substituted with one or two substituents, each substituent independently selected from halo or C n is an integer of value 1 or 2; or a pharmaceutically acceptable salt thereof; provided that if R provided that the compound is other than